News

The German Center for Cardiovascular Research has carried out pioneering clinical Covid-19 research by making its clinical research platform available to the nationwide Network University Medicine (NUM) in 2020. Starting in 2022, the NUM will operate its own research platform...

An interdisciplinary research team from the University of Göttingen and Hannover Medical School (MHH) has detected significant changes in the heart muscle tissue of people who died from Covid-19. Damage to lung tissue has been the research focus in this area for some time and has...

Not much is known about Long Covid. A new study by the Mainz University Medical Center shows that around 40 per cent struggle with health problems for a long time after a corona infection. Almost 30 per cent complained that they had not returned to their original performance...

Despite successful treatment of narrowed aortic valves by catheter-assisted aortic valve implantation (TAVI), patients with severely scarred hearts are at significantly greater risk of dying within one year post-treatment. To date, patients have not received drug treatments to...

Why not just cut up the virus and render it harmless in this way? That is the idea for a new type of antiviral therapy. The first results in the Petri dish and the animal model are promising. Scientists from Göttingen and Hanover will receive 700,000 euros from the Federal Agency...

If the “ecosystem” of the intestinal bacteria, the so-called microbiome, is changed by drugs, this can have good and bad consequences. Researchers from several European countries want to find out how certain cardiovascular diseases and the microbiome influence each other - and...

Even at a distance of three meters, it takes less than five minutes for an unvaccinated person standing in the breath of a Covid-19-infected person to become infected, with almost 100 percent certainty. However, if both people wear well-fitting medical, or better yet, FFP2 masks,...

Should the tricuspid valve be treated at the same time as the mitral valve reconstruction? In cases of mild tricuspid valve insufficiency, cardiac surgery guidelines have not provided a clear answer. A transatlantic study now published in the New England Journal of Medicine and...

Heart failure with preserved ejection fraction was previously considered largely untreatable. An MDC team led by Professor Michael Gotthardt has now succeeded for the first time in improving cardiac function with the help of a synthetic nucleic acid, as the researchers report in...

In patients with heart failure, the heart can no longer pump a sufficient volume of blood around the body. Treatment options for a specific type of heart failure – known as ‘heart failure with preserved ejection fraction’ (HFpEF) – remain extremely limited, mainly because much...